Table 2.
Polyunsaturated fatty acid (PUFA) content in mixed cortex expressed as mean percentage of total fatty acid. Parentheses denote standard deviation; *p<0.05.
| DHA− | DHA+ | t(17) | |
|---|---|---|---|
|
| |||
| N | 9 | 10 | |
| ω-3 PUFA total | 13.24% (0.60) | 16.50% (0.66) | −11.21* |
|
| |||
| 18:3 ω-3 (ALA) | 0.01% (0.01) | 0.02 (0.01) | −1.01 |
| 18:4 ω-3 (SDA) | 0.02% (0.02) | 0.03% (0.02) | −1.64 |
| 20:3 ω-3 (ETE) | 0.007% (0.006) | 0.015% (0.007) | −2.88* |
| 20:5 ω-3 (EPA) | 0.004% (0.003) | 0.04% (0.02) | −4.85* |
| 22:3 ω-3 (DTA) | 0.05% (0.02) | 0.07% (0.03) | −2.38* |
| 22:5 ω-3 (DPA) | 0.10% (0.02) | 0.24% (0.05) | −8.18* |
| 22:6 ω-3 (DHA) | 13.05% (0.61) | 16.08% (0.62) | −10.69* |
|
| |||
| ω-6 PUFA total | 19.59% (0.88) | 13.99 (0.83) | 14.26* |
|
| |||
| 18:2 ω-6 (LA) | 0.82% (0.08) | 0.94% (0.10) | −2.79* |
| 18:3 ω-6 (GLA) | 0.002% (0.001) | 0.003% (0.003) | −1.54 |
| 20:2 ω-6 (EDA) | 0.07% (0.02) | 0.06% (0.01) | 1.17 |
| 20:3 ω-6 (DGLA) | 0.22% (0.03) | 0.35% (0.05) | −7.80* |
| 20:4 ω-6 (ARA) | 11.86% (0.54) | 9.59% (0.58) | 8.79* |
| 22:2 ω-6 (DDA) | 0.04% (0.02) | 0.04% (0.03) | −0.08 |
| 22:4 ω-6 (ADA) | 3.78% (0.23) | 2.46 (0.19) | 13.79* |
| 22:5 ω-6 (DPA) | 2.81% (0.21) | 0.56% (0.09) | 30.69* |
|
| |||
| ω-6/ω-3 ratio | 1.48 (0.10) | 0.85 (0.06) | 16.99* |
ALA: α-linolenic acid; SDA: stearidonic acid; ETE: eicosatrienoic acid; EPA: eicosapentaenoic acid; DTA: docosatrienoic acid; DPA: docosapentaenoic acid; DHA docosahexaenoic acid; LA: linoleic acid; GLA: γ-linolenic acid; EDA: eicosadienoic acid; DGLA: dihomo-gamma-linolenic acid; ARA: arachidonic acid; DDA: docosadienoic acid; ADA: adrenic acid